Hemogenyx Pharmaceuticals Share Discussion Threads

[david gruen] 24/10/2022 14:56

Get over yourself Tom.

[the chairman elect] 24/10/2022 14:35

The HEMO has awoken from its recent slumber!

[davevtsmummy] 27/9/2022 15:00

Baldrick..you have embarrassed yourself with that tip for VAL...what a nob !

[blackhorse23] 26/9/2022 00:00

Today BUYING stock MCL (LSE)

[badger60] 23/9/2022 08:49

Are you sure you don't mean "blagger"??

[baldrick1] 22/9/2022 11:51

Ot... Anyone nterested for a double bagger in a week?I put 100000 in val today.

[badger60] 17/9/2022 04:18

GrowonThere's no mention of Hemocasino in the article that you posted. Added to which there are many biotechnology companies both large and small which are seeking the CAT-T golden egg......so far with very limited success but billions in development costs and outlay.The chances of Hemocasino producing a commercially viable CAR-T product is virtually zero, along with the other 99% of biotechnology companies which are trying to do the same thing.

[badger60] 14/9/2022 08:39

GrowonDeltic has just re-rated itself with the 17 Mio funding. Now is an ideal opportunity to buy as the 3.5p issue price more or less is a safety net. Fully funded for Pensacola and now Selene in partnership with Shell. Also 5 CNE joint NS prospects which are currently work in progress...........or stick with Hemocasino....and get shafted when the money runs out.

[david gruen] 12/9/2022 07:25

Hasn't been any serious rampers on here for over two years Term. Surely there's better threads from where you can gain your much desired attention fix?

[ashleyjv] 01/9/2022 09:48

Wouldn't want to go in empty handed

[sweepie2] 01/9/2022 09:27

News before conference imho

[ashleyjv] 01/9/2022 09:00

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce its participation in the H.C. Wainwright 24th Annual Global Investment Conference to be held on September 12-14, 2022, in New York City . The Company will be featured as a presenting company. The conference will be hosted both in person as well as virtually under a hybrid model.

As part of the Company's presentation, Dr Vladislav Sandler, CEO of Hemogenyx Pharmaceuticals, will provide an overview of the Company's business, product candidates and their progression toward clinical trials.

The conference will feature corporate presentations, panels, and one-on-one investor meetings. Dr Sandler's presentation will be accessible using a webcast link for registered conference participants.

Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "Our presentation at the H.C. Wainwright 24th Annual Global Investment Conference provides the Company with a great opportunity to inform the investment community about our achievements and increase the Company's visibility globally. It also allows us to further establish Hemogenyx Pharmaceuticals as a leader in the field of the development of medicines for treatment of blood and autoimmune diseases."

[david gruen] 25/8/2022 11:21

Awww bless. Purging your OPTI anger on here!

So transparent.

[bahamarama] 24/8/2022 23:35

Not an awful lot of money lost on the drop from the last push... yet...But plenty made from 1.15 to the recent high. (If you happen to be a trader and not a long term desperado wondering how it all went so terribly wrong..??).The next low is going to be at the sub penny mark...And Badgers are STILL my favourite monochromatic quadrupeds..!!!

[badger60] 23/8/2022 11:01

Oh look!!! DELT is up again today...